A Review Study of Infliximab and Methotrexate Use In Management of Rheumatoid Arthritis

The present study is designed to review whether the combination therapy of Infliximab and Methotrexate is better than Methotrexate monotherapy. We have reviewed that combination therapy of TNF- inhibitors and Methotrexate in RA. How TNF-alpha inhibitors (Infliximab) and Methotrexate performed in randomized controlled trials when compared to Methotrexate in Methotrexate naive Rheumatoid Arthritis patients.